Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Flowscape customer expands to 31,000 desks in 34 countries

One of Flowscape's global customers continues its expansion and increases the total number of bookable desks to 31,000 in 100 buildings across 34 countries. This order, which is for the latest expansion, has a value in the first year of SEK 480,000 and thereafter SEK 180,000 annually“This customer installation is probably one of the largest smart office installations in the world covering 31,000 bookable desks, 7,000 bookable rooms and office maps of 900,000 square meters, all for the same customer. The solution is important for the customer's strategy to create even more attractive offices

BioStock: Cereno Scientific intends to initiate a phase II study in September

At the end of last week, Cereno Scientific announced that the timeline for the upcoming phase II trial with drug candidate CS1 has been set.  The announcement comes after the signing of the final collaboration agreement with clinical research organisation (CRO) Worldwide Clinical Trials. According to the timeline, the first patient with the rare disease pulmonary arterial hypertension (PAH) will receive treatment in September 2021, and study results will be presented during the second half of 2022.Read the full article at biostock.se: https://www.biostock.se/en/cereno-scientific-intends-

Publication of clinical Phase I/IIa data in the RH5 blood-stage malaria vaccine

Hørsholm, Denmark, April 21, 2021 – ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) and its protein production platform ExpreS2™ have contributed to a scientific article published in the journal Med. The article highlights the outcome of the VAC063-study, a Phase I/IIa clinical trial to assess the safety, immunogenicity and efficacy of the blood-stage Plasmodium falciparum malaria vaccine candidate RH5.1/AS01\B\. In conclusion the RH5.1/AS01\B\ vaccine is safe, well tolerated, and immunogenic in healthy adults. A significantly reduced blood-stage parasite growth rate was observed in vaccinees

poLight ASA – poLight received another purchase order for web camera product

Horten, 21 April 2021 - poLight ASA (OSE: PLT) today announced that the company has received a purchase order for TLens of approximately NOK 450 000. The purchase order is related to the web camera customer announced on the 6th of April this year. “This follow-up order came quicker than we anticipated and is potentially a sign of good initial feedback from their distribution channels.  We have not anticipated this particular case to represent high volume, however given the increased interaction between people on video conferencing, this is an important show case for the company as the

BillerudKorsnäs launches new generation of coated liner from KM7

With Pure DecorX™, BillerudKorsnäs is introducing the latest development in White Top Kraftliner. The launch opens up great improvement potential for decorative corrugated packaging, in terms of strength, print appearance and sustainability. Pure DecorX is a 3-ply construction made of 100% primary wood fibres, which makes the liner strong, stiff and with high thickness. In practice, this means great lightweighting opportunities, high runnability in converting machines, reduced risk of washboarding, and enhanced packaging performance. The use of only primary fibres also makes Pure

BEWI publishes annual report for 2020

BEWI, a leading provider of packaging, components, and insulation solutions, today publishes the company’s annual report for 2020.The board of directors of BEWI ASA has approved the annual report for 2020. The financial statements for the full year of 2020 have no material deviations from the preliminary accounts published together with the results for the fourth quarter of 2020 on 24 February 2021. “2020 was a good year for BEWI. We delivered solid operational performance and profitable growth. More importantly, our people continued to deliver and to serve our customers with no

BEWiSynbra publishes annual report for 2020

BEWiSynbra, a leading provider of packaging, components, and insulation solutions, today publishes the company’s annual report for 2020.The board of directors of BEWiSynbra Group AB has approved the annual report for 2020. The financial statements for the full year of 2020 have no material deviations from the preliminary accounts published together with the results for the fourth quarter of 2020 on 24 February 2021. “2020 was a good year for BEWI. We delivered solid operational performance and profitable growth. More importantly, our people continued to deliver and to serve our customers

PowerCell Sweden establishes presence in the Norwegian market

PowerCell Sweden AB (publ)  has decided to establish a local presence in the Norwegian market.“As a market, Norway is a clear leader in the use of hydrogen electrification, pursuing the establishment of infrastructure and a value chain, thereby providing excellent possibilities for creating commercially enduring business opportunities for our customers,” says PowerCell Sweden AB’s CEO Richard Berkling, justifying the initiative.PowerCell Sweden AB will evaluate the conditions for local establishment, and intends to revert with more detailed information during the

The Board of Directors of Castellum has resolved on repurchases of own shares

The Board of Directors of Castellum AB (publ) has, based on the authorisation from the Annual General Meeting held on 25 March 2021, resolved on repurchases of own shares.The purpose of the repurchases is to be able to adapt the capital structure of the company to its capital needs and thereby contribute to an increased shareholder value. Castellum’s financial position is solid. The Board of Directors’ assessment is that there is room for exe­cuting the repurchases and, at the same time, meet the financing and liquidity requirements of the business. The repurchases may be carried out on

Colecalciferol EQL Pharma Approval

The pharmaceutical Colecalciferol EQL Pharma tablets 800IU and 2000IU has been approved by the Irish Medicines Agency (HPRA) for sale. Approvals are also expected soon from the Netherlands, Norway and Sweden.Colecalciferol EQL Pharma is a prescription drug that contains Vitamin D3, which helps with the uptake and storage of calcium in the skeleton. It is often given as a preventive treatment for osteoporosis. Colecalciferol EQL Pharma will be launched in Sweden during the company's fourth financial quarter. In Sweden, the market today is valued at SEK 69m with two active competitors. For

Notice to attend the Annual General Meeting of Sivers Semiconductors AB (publ)

The shareholders in Sivers Semiconductors AB (publ) (the “Company”), reg. no. 556383-9348, are hereby invited to attend the Annual General Meeting to be held on Thursday 20 May 2021, only by postal vote.Due to the coronavirus and in an effort to reduce the spread, the Board of Directors has resolved that the Annual General Meeting will be held without the physical presence of shareholders, representatives and third parties, and that the shareholders will only be able to exercise their voting rights through postal voting in accordance with the instructions specified below. Information

High level of activity and stable earnings

· Income for the period January–March 2021 totalled MSEK 1,502 (1,476). · Income from property management amounted to MSEK 779 (794), equivalent to SEK 2.82 (2.91) per share – a change of –3%. · Change in value on properties amounted to MSEK 1,607 (3) and on derivatives to MSEK 19 (–167). · Net income for the period amounted to MSEK 3,840 (482), corresponding to SEK 13.90 (1.76) per share. · Long-term net reinstatement value (EPRA NRV) amounted to SEK 220 per share (193), an increase of 14%. · Net investments amounted to MSEK –9,014 (643) of which MSEK 177 (75) pertained to

AQ Group AB (publ), interim report January - March, 2021

First quarter, January - March 2021 in brief · Organic growth and continued good cost control resulted in a sharp increase in operating profit in the quarter · Net sales decreased by 2.6% to SEK 1,307 million (1,342) · Operating profit (EBIT) increased by 23.7% to SEK 121 million (98) · Profit after financial items (EBT) increased by 45.0% to SEK 126 million (87) · Profit margin before tax (EBT %) was 9.6% (6.5) · Cash flow from operating activities increased to SEK 160 million (141) · Earnings per share after tax amounted to SEK 5.89 (4.11) · Equity ratio was 56% (

World’s Longest Indoor Autonomous Vehicle Test Track Now Open

The automotive industry is undergoing change and tests and trials are being conducted more agilely. AstaZero is now opening the world’s longest indoor track for testing active safety systems and autonomous technologies for all types of vehicles. Vehicle operators are able to conduct tests 24 hours a day, 365 days a year with reproducible light and surfaces.AstaZero is the world’s first full-scale independent testing and demonstration facility for future road safety, and it is now being expanded to house the world’s longest indoor track: 700 metres long and 40 metres wide. AstaZero Dry Zone

Kemira appoints Terhi Kivinen as Chief Communications Officer

Kemira OyjPress releaseApril 21, 2021 at 9.00 am (EEST)Kemira appoints Terhi Kivinen as Chief Communications Officer  Kemira has appointed Terhi Kivinen as Chief Communications Officer of Kemira Oyj starting from May 1, 2021. Terhi Kivinen joined Kemira as Director Global Communications and Stakeholder Relations in March 2020 and prior to Kemira has had a long career in communications, IR, sustainability and marketing in international and Finnish organizations. She will report to Jari Rosendal, President & CEO of Kemira Oyj in her new role.

Nexam Chemical Holding AB (publ) Interim Report 1 January – 31 March 2021

Growth by 26% and best quarter to dateFirst quarter at a glance Significant events: · Continued high growth, +26% compared to the corresponding quarter in 2020. · Both Performance Chemical, + 38%, and Performance Masterbatch, + 15%, are growing compared to the corresponding quarter in 2020. · First commercial order to India amounted to SEK 1,500,000 shipped during the quarter. · Directed new share issue oversubscribed, added SEK 33,534,000 after deduction of transaction costs. · Reactive Recycling, a new offering in recycling, was launched during the quarter.

Solid first quarter – we believe in the future of the office

· Rental income increased to SEK 293 million (285) · Income from property management decreased to SEK 167 million (183) · Profit for the period amounted to SEK 365 million (429) · Property portfolio increased to SEK 22,969 million (22,575) · Earnings per share totalled SEK 3.03 (3.56) · Green financing increased to 61% · Charlotte Hybinette new Chairman of the Board of Platzer · Detailed development plan for Gamlestadens Fabriker becomes legally binding Platzer’s CEO, P-G Persson, said: - Despite the continued problems in society as a consequence of the pandemic,

Interim Report for the period January – March 2021

New data continues to strengthen lecanemabEvents during the first quarter 2021 · BioArctic presented findings at the AD/PD conference suggesting that lecanemab could be developed into a disease modifying treatment for individuals with Down’s syndrome with dementia. · New preliminary results presented from the ongoing open-label extension of the Phase 2b study in early Alzheimer’s disease continued to support the effect of the drug candidate lecanemab on brain amyloid levels. Events after the period · Lecanemab Phase 2b study results in early Alzheimer’s disease published in

Invitation to Eltel’s Q1 2021 report presentation

Eltel will publish its interim report for the first quarter 2021 on Wednesday 28 April 2021 at approximately 08:00 am CEST. On the same day, we are inviting investors, analysts and media to a webcast starting at 11:00 am CEST.The report for the first quarter 2021 will be presented live by Eltel’s CEO Casimir Lindholm and CFO Saila Miettinen-Lähde. The presentation will be held in English. Link to webcast: www.eltelgroup.com. During the presentation, there will be an opportunity to ask questions via the webcast. The presentation material as well as a recording of the webcast will be

Next Phase of ERAS® – Opportunities & Challenges

To date, ERAS has achieved significant benefit for patients and health systems; however, improvements are still needed, particularly in the areas of patient optimization and systematic implementation. During this time of global crisis, the ERAS method of delivering care is required to take surgery and anesthesia to the next level and bring improvements in outcomes to both patients and health systems. For more details, please read here Next Phase ERAS  Encare offers the ERAS® Interactive Audit System 

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Klaria Receives Third Payment from the EU Horizon 2020 Program Supporting the Development of the Sumatriptan Alginate Film

Klaria reports that it has successfully performed and reported the planned activities under the ongoing European Commission Horizon 2020 Innovation Grant (Grant Number 8296159).  The third payment, totaling ca. 2 million SEK has now been confirmed by the EU.  Klaria has thus far received approximately 18,5 million SEK of the total 21 million SEK specified in the grant agreement.  The project will end on June 30[th] of this year and Klaria anticipates receiving the full remaining balance upon successful completion of the final report to the EU.The Horizon 2020 program supporting the

The world’s first demand-controlled ventilation system as a service for commercial kitchens

Technology leader in demanding ventilation, Halton Group, will begin providing their demand-controlled ventilation system, the Halton M.A.R.V.E.L, to commercial kitchens as a service which makes its benefits more conveniently available to more food service operators, such as restaurants, by minimizing the capital cost of the system.The Halton M.A.R.V.E.L system, connected via IoT, helps ensure continuous operation and predictable expenses in professional kitchens through predictive maintenance, and can significantly cut their energy costs and carbon footprint. Commercial kitchens use around

There are no items matching the current filter
There are no more items matching the current filter
Back to top